Mutagenesis of the Cyclic AMP Receptor Protein of Cyclic Nucleotide
Total Page:16
File Type:pdf, Size:1020Kb
Q--DI 1993 Oxford University Press Nucleic Acids Research, 1993, Vol. 21, No. 8 1827-1835 Mutagenesis of the cyclic AMP receptor protein of Escherichia cofi: targeting positions 72 and 82 of the cyclic nucleotide binding pocket Ali O.Belduz+, Eun Ju Lee and James G.Harman* Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409-1061, USA Received January 11, 1993; Revised and Accepted March 12, 1993 ABSTRACT The 3', 5' cyclic adenosine monophosphate (cAMP) Three conformational states of CRP are known: native CRP binding pocket of the cAMP receptor protein (CRP) of and complexes having either one or both of the cAMP binding Escherichia coli was mutagenized to substitute leucine, sites occupied by cAMP (6). The CRP:(cAMP), conformer glutamine, or aspartate for glutamate 72; and lysine, appears to be the relevant active form in vivo, considering both histidine, leucine, isoleucine, or glutamine for arginine the intracellular cAMP concentrations in bacteria and the 1:1 82. Substitutions were made in wild-type CRP and in stoichiometry of CRP to cAMP observed in the CRP:cAMP:gal a CRP*, or cAMP-independent, form of the protein to DNA and CRP:cAMP:lac DNA complexes formed in vitro assess the effects of the amino acid substitutions on (7-9). Details of the changes in CRP structure that result upon CRP structure. Cells containing the binding pocket binding one or two molecules of cAMP are incomplete; crystals residue-substituted forms of CRP were characterized of the CRP and the CRP:(cAMP)1 conformers have not yet been through ,B-galactosidase activity and by measurement obtained. Detailed structure analysis information available for of cAMP binding activity. This study confirms a role for the CRP:(cAMP)2 conformer (10) has provided a basis for both glutamate 72 and arginine 82 in cAMP binding and understanding both cAMP-mediated and mutational activation of activation of CRP. Glutamine or leucine substitution of CRP (11-14), and proposals have been advanced on the probable glutamate 72 produced forms of CRP having low affinity effects of cAMP on wild-type CRP. for the cAMP and unresponsive to the nucleotide. Analysis of the CRP:(cAMP)2 crystal structure identified five Aspartate substituted for glutamate 72 produced a low specific amino acid-ligand contacts that are considered important affinity cAMP-responsive form of CRP. CRP has a in cAMP binding to CRP and/or in mediating cAMP activation stringent requirement for the positioning of the position of CRP (13). The authors suggested that the charged phosphate 72 glutamate carboxyl group within the cyclic of cAMP interacts with arginine 82 to form a salt bridge, and nucleotide binding pocket. Results of this study also that specific hydrogen bond interactions occur between a) the indicate that there are differences in the binding axial phosphate oxygen atom of the 3' :5' cyclic phosphate ring requirements of cAMP and cGMP, a competitive and serine 83 b) the 2' hydroxyl of ribose and glutamate 72, and inhibitor of cAMP binding to CRP. c) the N6 amino group of adenine and threonine 127 of one subunit and serine 128 of the other subunit. We have undertaken a study designed to assess the effects of specific amino acid INTRODUCTION substitutions at these positions in CRP to test the predictions of The cyclic 3':5'-adenosine monophosphate (cAMP) receptor the CRP:(cAMP)2 crystal structure analysis for CRP in solution. protein (CRP) ofEscherichia coli is a dimeric protein that binds This study includes analysis of substitutions contained in both to both cyclic nucleotides and, in the presence of cAMP, to wild-type CRP and in a cAMP-independent form of CRP (CRP*) specific DNA sequences located in a number of E. coli promoter that mediates CRP-dependent gene expression in the absence of regions (1). Binding of CRP:cAMP to a promoter region either cAMP (15). stimulates or represses the activity of that promoter depending Many crp* alleles have amino acid substitutions located outside upon the relative locations of the CRP and RNA polymerase of the cAMP binding pocket (12, 14-17). One such mutant, 91 binding sites. The activation of CRP as a transcription control CRP (reference 15, hereafter referred to as CRP*[A14T]), element is initiated by the binding of cAMP. Biochemical contains threonine in place of alanine 144 located in the DNA evidence clearly indicates that cAMP binding alters CRP binding domain of CRP. This substitution renders CRP conformation and induces DNA sequence specific recognition conformation similar to that of the active cAMP-modified (reviewed in 1 and 2). Cyclic nucleotides other than cAMP (i.e., conformation of the wild type CRP:cAMP complex (15). The cGMP) bind CRP but fail to activate the protein (3-5). inherent transcription control activity of many forms of CRP* * To whom correspondence should be addressed + Present address: Karadeniz Technical University, Department of Biology, 61080-Trabzon, Turkey 1828 Nucleic Acids Research, 1993, Vol. 21, No. 8 (including CRP*[AI44T]) is stimulated by both cAMP and cGMP. from Difco Laboratories. 3'-5' cAMP, 3'-5' cGMP and subtilisin CRP* forms of CRP are thought to be intermediate in both BPN' (type XXVII, 7.9 units/mg) were purchased from Sigma conformation and activity between the active and inactive Chemical Company. 3H (2'-8' labeled) 3'-5' cAMP (31.3 conformations of wild type CRP; they are capable of undergoing Ci/mol), C-35 S-labeled ATP (500 Ci/mol) and a-32 P-labeled a conformation change upon binding of cyclic nucleotide, and ATP (3000 Ci/mol) were purchased from New England Nuclear. have lost the capacity to discriminate between cAMP and cGMP. XAR-5 X-ray film was obtained from Eastman Kodak. Synthetic We report here the results of our analysis of CRP mutants with oligonucleotides were purchased from Midland Certified Reagent amino acid substitutions at positions 72 and 82 of the cyclic Company. Qiagen DNA isolation kits were purchased from nucleotide binding pocket. The effects of these substitutions on Qiagen, Inc. Common salts and buffer components were reagent CRP function were assessed by measuring the capacity of mutant grade or better. CRP, expressed in a Acya Acrp strain of E.coli, to support f- galactosidase synthesis in the absence of cAMP, in the presence Construction of M13crp of cAMP or in the presence of cGMP. Partially purified CRP The 1321 bp Alu I DNA fragment of pKC30crp (15) was cloned preparations were utilized to measure mutant CRP affinity for into Sma I-digested, alkaline phosphatase-treated M13mp 18 cAMP at physiologically relevant salt and cAMP concentrations. DNA. The ligation mixture was used to transform competent Parallel cAMP binding pocket mutants contained in the E. coli TG- 1 cells. Single stranded DNA was isolated and CRP*[Al44T] background provided a measure of whether specific sequenced to confirm that the DNA from one of the resultant amino acid substitutions resulted in only local perturbations or plaques, designated M 13crp, contained the cmp gene. in global changes in CRP*[Al44T] structure. The results of this study confirm the importance of both glutamate 72 and arginine Site directed mutagenesis of the E.coli cmp gene 82 in cAMP binding and in cAMP-mediated activation of CRP. Introduction ofa Nde I site. Mutagenesis of cmp was accomplished using the method of Kunkel (22) as outlined in the protocol MATERIALS AND METHODS provided by Bio-Rad Laboratories. Uracil-containing M13cmp DNA was annealed to a mutagenic primer (pGATAA- Bacterial strains and plasmid DNA CCGCATATGGTGCTTGGCoH) and replicated in vitro to E.coli strains CA8445/pRK248 (Acya 845, Acrp 45, thilXclts, introduce a Nde I restriction endonuclease site that utilized the tetr) (15) and D1210HP [hsd S20 (rB; mB), sup E44, ara 14, ATG start codon in the cmp structural gene. Mutagenized DNA gal K2, lac Y1, pro A2, rps L20, xyl -5, mtl -1, rec A13, (rB-; was used to transform competent E. coli MV 1190 cells. The Nde mBO), mcr A+, mcr B-, XcIts, xis-, kil-, int+] (Stratagene) I/Sac I fragment containing the crp structural gene of one mutant were used as hosts for recombinant crp plasmids. E. coli strains (M13cmp NdeI) was subcloned into Nde I/,Sac I-digested, alkaline TG-1 [A (lac -pro) thi, sup E, hsd D5, fF':tra D36, pro AB, phosphatase-treated pRE2. The ligation mixture was used to lac Iq, lac ZAM15}] (18) and XL-1 Blue [X-, rec A1, end A 1, transform competent E.coli D121OHP. Supercoiled plasmid DNA gyr A96, thi, hsd 17, sup E44, rel Al, (lac), [F', pro AB, lac isolated from from one ampicillin resistant isolate, designated Iq, lac ZAM15, TnlO (tetr)j] (Stratagene) were used to propagate pRE2cmp, was sequenced using cmp sequencing primers (15) to M13mpl 8 (19) and its crp-containing derivatives. E. coli strains confirm the sequence of the construct. DNA sequencing reactions MV1 190 [,A(lac -pro) thi, sup E, A(srl-rec A0306: :TnlO were run as outlined in the protocols provided by New England tetr)[F':tra D36, pro AB, lac Iq, lac ZAM15a] (Bio-Rad Biolabs and by United States Biochemical Corporation, Inc. Laboratories) and CJ236 [dut, ung, thi, rel AfpCJ105 (cmr)J] (Bio-Rad Laboratories) were used for mutagenesis of cmp. Plasmid Introduction ofcyclic nucleotide binding pocket mutations. The was of California pRK248 (20) the gift of D.Helinski, University cmp gene was mutagenized as described above using uracil- at San Diego, La Jolla, CA. pKC30crp (15) containing wild type containing Ml13cmp NdeI DNA as template and the following crp cloned downstream of the XPL promoter was used as the mutagenic primers. Position 72; ATTGGCGACCTGGGCC (G- source of the cmp structural gene.